Exclusive Content
QDENGA: A Milestone in India’s Battle Against Dengue
The onset of monsoon in India apart from bringing relief from the sweltering heat marks the rise of dengue cases. Every year, lakhs of people infected by...
Medtronic MEIC Expands Breast and Cervical Cancer Screenings in Hyderabad
The Medtronic Engineering and Innovation Center (MEIC) in Hyderabad has initiated a series of health and development initiatives aimed at uplifting underserved local communities.
Driven by Medtronic’s core mission...
Lupin Introduces Kaveri Therapeutics to Accelerate Cancer Drug Development
Lupin Limited announced the strategic spin-out of two promising oncology assets LNP7457 (PRMT5) and LNP8701 (SOS1) into Kaveri Therapeutics Inc. , a U.S.-based, clinical-stage oncology company dedicated to advancing targeted...
CBN India Seizes Illicit Trafficking of 12 Crore Tramadol Tablets under “Operation Vajra”
The Central Bureau of Narcotics (CBN) successfully executed “Operation Vajra,” seizing a massive export consignment of 120 million (12 crore) high-strength Tramadol Hydrochloride tablets....
DCGI Approves Qdenga, Marking India’s First Dengue Vaccine
Takeda Biopharmaceuticals India has received market authorisation from the Drug Controller General of India (DCGI) for Qdenga, making it the country's first licensed dengue vaccine....
NATCO Gets USFDA Nod for Generic Cancer Drug Olaparib
Alembic Pharmaceuticals Limited announced that its development partner, NATCO Pharma Limited (NATCO), has received tentative approval from the U.S. Food and Drug Administration (USFDA)...